# Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery

> **NCT03739528** · PHASE3 · COMPLETED · sponsor: **NTC srl** · enrollment: 808 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Levofloxacin + dexamethasone followed by dexamethasone
- **DRUG:** Tobramycin + Dexamethasone

## Key facts

- **NCT ID:** NCT03739528
- **Lead sponsor:** NTC srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-03
- **Primary completion:** 2018-12-19
- **Final completion:** 2018-12-19
- **Target enrollment:** 808 (ACTUAL)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739528, "Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03739528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*